Versant Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Versant Capital Management’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72K	Buy	148 +14	+10%	+$226	﹤0.01%	2528
2026 Q1	$2.62K	Hold	134	–	–	﹤0.01%	2521
2025 Q4	$4.17K	Hold	134	–	–	﹤0.01%	2316
2025 Q3	$2.89K	Hold	134	–	–	﹤0.01%	2346
2025 Q2	$1.87K	Sell	134 -179	-57%	-$2.43K	﹤0.01%	2394
2025 Q1	$4.22K	Buy	313 +231	+282%	+$3.94K	﹤0.01%	2083
2024 Q4	$1.57K	Buy	+82	New	+$1.78K	﹤0.01%	2106

Other funds holding VRDN

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Eleva Capital Paris, France $343M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Torren Management San Diego, California $197M AUM